Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 138

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 9C
Chunk 138
---
; and consultants of our company or our affiliates, and our
directors, including our non-employee directors.

Types
of Awards

The
2023 Omnibus Plan permits the Administrator to grant stock options, stock appreciation rights (“SARs”), performance shares,
performance units, shares of common stock, restricted stock, restricted stock units (“RSUs”), cash incentive awards, dividend
equivalent units, or any other type of award permitted under the 2023 Omnibus Plan. The Administrator may grant any type of award to
any participant it selects, but only our employees or our subsidiaries’ employees may receive grants of incentive stock options
within the meaning of Section 422 of the Internal Revenue Code. Awards may be granted alone or in addition to, in tandem with, or (subject
to the repricing prohibition described below) in substitution for any other award (or any other award granted under another plan of our
company or any affiliate, including the plan of an acquired entity).

64

Shares
Reserved Under the 2023 Omnibus Incentive Plan

The
2023 Omnibus Plan will provide that 6,500,000 shares of our common stock are reserved for issuance under the 2023 Omnibus Plan, all of
which may be issued pursuant to the exercise of incentive stock options. The number of shares available for issuance under our 2023 Omnibus
Plan will also include an annual increase on the first day of each fiscal year after the completion of the initial public offering on
February 9, 2024 equal to 1.0% of the outstanding shares of all class of our common stock as of the last day of the immediately preceding
fiscal year or such other amount as our board of directors may determine.

The
number of shares reserved for issuance under the 2023 Omnibus Plan will be reduced on the date of the grant of any award by the maximum
number of shares, if any, with respect to which such award is granted. However, an award that may be settled solely in cash will not
deplete the 2023 Omnibus Plan’s share reserve at the time the award is granted. If (a) an award expires, is canceled, or terminates
without issuance of shares or is settled in cash, (b) the Administrator determines that the shares granted under an award will not be
issuable because the conditions for issuance will not be satisfied, (c) shares are forfeited under an award, (d) shares are issued under
any